GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » EV-to-EBIT

MediClin AG (XTER:MED) EV-to-EBIT : 32.67 (As of Apr. 29, 2024)


View and export this data going back to 2000. Start your Free Trial

What is MediClin AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MediClin AG's Enterprise Value is €498.5 Mil. MediClin AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €15.3 Mil. Therefore, MediClin AG's EV-to-EBIT for today is 32.67.

The historical rank and industry rank for MediClin AG's EV-to-EBIT or its related term are showing as below:

XTER:MED' s EV-to-EBIT Range Over the Past 10 Years
Min: -1487   Med: 20.32   Max: 2291.53
Current: 32.67

During the past 13 years, the highest EV-to-EBIT of MediClin AG was 2291.53. The lowest was -1487.00. And the median was 20.32.

XTER:MED's EV-to-EBIT is ranked worse than
77.34% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.475 vs XTER:MED: 32.67

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MediClin AG's Enterprise Value for the quarter that ended in Dec. 2023 was €494.8 Mil. MediClin AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €15.3 Mil. MediClin AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.08%.


MediClin AG EV-to-EBIT Historical Data

The historical data trend for MediClin AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG EV-to-EBIT Chart

MediClin AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.90 2,255.00 43.02 28.71 32.43

MediClin AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.71 25.85 20.32 12.20 32.43

Competitive Comparison of MediClin AG's EV-to-EBIT

For the Medical Care Facilities subindustry, MediClin AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MediClin AG's EV-to-EBIT falls into.



MediClin AG EV-to-EBIT Calculation

MediClin AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=498.489/15.259
=32.67

MediClin AG's current Enterprise Value is €498.5 Mil.
MediClin AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediClin AG  (XTER:MED) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MediClin AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=15.259/494.799
=3.08 %

MediClin AG's Enterprise Value for the quarter that ended in Dec. 2023 was €494.8 Mil.
MediClin AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediClin AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MediClin AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MediClin AG (XTER:MED) Business Description

Traded in Other Exchanges
Address
Okenstrasse 27, Offenburg, DEU, 77652
MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.